Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 415Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India

Altaf Mohammed, Zubedi Ayesha Mubeen, Nazneen Fareesa, Kareemulla Shaik, Ali Syed Amir, Aleemuddin N M, Hannan Hazari Md. Abdul

Year : 2015| Volume: 6| Issue : 3 | Page no: 150-158

   This article has been cited by
 
1 Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Brian Godman,Holly McCabe,Trudy D Leong,Debjani Mueller,Antony P. Martin,Iris Hoxha,Julius C. Mwita,Godfrey Mutashambara Rwegerera,Amos Massele,Juliana de Oliveira Costa,Renata Cristina Rezende Macedo do Nascimento,Livia Lovato Pires de Lemos,Konstantin Tachkov,Petya Milushewa,Okwen Patrick,Loveline Lum Niba,Ott Laius,Israel Sefah,Suhaj Abdulsalim,Fatemeh Soleymani,Anastasia N Guantai,Loice Achieng,Margaret Oluka,Arianit Jakupi,Konstantins Logviss,Mohamed Azmi Hassali,Dan Kibuule,Francis Kalemeera,Mwangana Mubita,Joseph Fadare,Olayinka O. Ogunleye,Zikria Saleem,Shazhad Hussain,Tomasz Bochenek,Ileana Mardare,Alian A. Alrasheedy,Jurij Furst,Dominik Tomek,Vanda Markovic-Pekovic,Enos M. Rampamba,Abubakr Alfadl,Adefolarin A Amu,Zinhle Matsebula,Thuy Nguyen Thi Phuong,Binh Nguyen Thanh,Aubrey Chichonyi Kalungia,Trust Zaranyika,Nyasha Masuka,Ioana D. Olaru,Janney Wale,Ruaraidh Hill,Amanj Kurdi,Angela Timoney,Stephen Campbell,Johanna C. Meyer
Expert Review of Pharmacoeconomics & Outcomes Research. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications
Holly McCabe,Brian Godman,Amanj Kurdi,Katie Johnston,Sean MacBride-Stewart,Janey Lennon,Simon Hurding,Marion Bennie,Alec Morton
Expert Review of Respiratory Medicine. 2019; 13(7): 679
[Pubmed]  [Google Scholar] [DOI]
3 Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized ß2-Agonists
Vamsi Bollu,Annie Guérin,Geneviève Gauthier,Robert Hiscock,Eric Q. Wu
Drugs - Real World Outcomes. 2016;
[Pubmed]  [Google Scholar] [DOI]
4 Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies
M. H. Roberts,M. E. Borrego,A. A. Kharat,P. L. Marshik,D. W. Mapel
Expert Review of Pharmacoeconomics & Outcomes Research. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Importance of Economic Evaluation in Health Care: An Indian Perspective
Amit Dang,Nishkarsh Likhar,Utkarsh Alok
Value in Health Regional Issues. 2016; 9: 78
[Pubmed]  [Google Scholar] [DOI]

 

Read this article